» Articles » PMID: 33991143

Calcium and Phosphate Homeostasis in Dogs with Newly Diagnosed Naturally Occurring Hypercortisolism

Overview
Date 2021 May 15
PMID 33991143
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypercortisolism affects calcium and phosphate metabolism in dogs; however, the exact mechanisms are not completely understood.

Objectives: To evaluate circulating concentrations of whole parathormone (wPTH), 25-hydroxyvitamin D (25-(OH)D), calcitriol, and fibroblast growth factor-23 (FGF-23) in dogs with naturally occurring hypercortisolism (NOHC) and healthy dogs, and their association with calcium and phosphate homeostasis.

Animals: Twenty-three client-owned dogs with NOHC, and 12 client or staff-owned healthy dogs.

Methods: Prospective cross-sectional study. The circulating concentrations of total calcium, ionized calcium (iCa), phosphate, wPTH, 25-(OH)D, calcitriol and FGF-23, and the urinary fractional excretion of phosphate (FEP) and calcium (FECa) were compared between dogs with NOHC before treatment and healthy dogs.

Results: Dogs with NOHC had higher mean serum phosphate concentrations (4.81 mg/dL, SD ± 0.71 vs 3.86 mg/dL, SD ± 0.60; P < .001), median FECa (0.43%, range, 0.03-2.44 vs 0.15%, range, 0.06-0.35; P = .005), and median serum wPTH concentrations (54.6 pg/mL, range, 23.7-490 vs 24.6 pg/mL, range, 5.5-56.4; P = .003) as compared to the controls. Circulating concentrations of total calcium, iCa, and calcitriol and the FEP did not differ between groups, whereas the serum 25-(OH)D concentrations were lower in dogs with NOHC as compared to the controls (70.2 pg/mL, SD ± 42.3 vs 106.3 pg/mL, SD ± 35.3; P = .02). The dogs with NOHC had lower plasma FGF-23 concentrations than controls (316.6 pg/mL, range, 120.8-575.6 vs 448.7 pg/mL, range, 244.8-753; P = .03).

Conclusions And Clinical Importance: Urine loss of calcium and hyperphosphatemia could contribute to the adrenal secondary hyperparathyroidism.

Citing Articles

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.

Oh Y, An J, Lim G, Park S, Kim T, Seo K BMC Vet Res. 2024; 20(1):227.

PMID: 38790012 PMC: 11127328. DOI: 10.1186/s12917-024-04030-x.


Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism.

Corsini A, Dondi F, Serio D, Zamagni S, Golinelli S, Fernandez M J Vet Intern Med. 2021; 35(3):1265-1273.

PMID: 33991143 PMC: 8163130. DOI: 10.1111/jvim.16143.

References
1.
Parker V, Harjes L, Dembek K, Young G, Chew D, Toribio R . Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. J Vet Intern Med. 2017; 31(3):791-798. PMC: 5435068. DOI: 10.1111/jvim.14653. View

2.
Karmali R, Farrow S, Hewison M, Barker S, ORIORDAN J . Effects of 1,25-dihydroxyvitamin D3 and cortisol on bovine and human parathyroid cells. J Endocrinol. 1989; 123(1):137-42. DOI: 10.1677/joe.0.1230137. View

3.
Akeno N, Matsunuma A, Maeda T, Kawane T, Horiuchi N . Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol. 2000; 164(3):339-48. DOI: 10.1677/joe.0.1640339. View

4.
Seeman E, Kumar R, Hunder G, Scott M, Heath 3rd H, Riggs B . Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest. 1980; 66(4):664-9. PMC: 371639. DOI: 10.1172/JCI109902. View

5.
Corsini A, Dondi F, Serio D, Zamagni S, Golinelli S, Fernandez M . Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism. J Vet Intern Med. 2021; 35(3):1265-1273. PMC: 8163130. DOI: 10.1111/jvim.16143. View